a patient with vasculitis shall be said to have giant cell temporal arteritis if at least three of these five criteria are present. Giant cell arteritis (GCA) is a medical emergency. The concept ...

Individuals with type 2 diabetes or a higher BMI may face a reduced risk of developing GCA, while a history of cardiovascular disease may increase this risk.

GCA, giant cell arteritis; PET, positron emission tomography ... Furthermore, the data showed that the diagnosis had been made based on clinical criteria or physician’s judgement without TAB or ...

Objectives To characterise factors associated with permanent vision loss (PVL) and potential reasons for the therapeutic delay contributing to PVL in giant cell arteritis (GCA ... if the 1990 criteria ...

In this Healio Video Perspective, Andrew G. Lee, MD, discusses whether temporal artery ultrasound can be used in place of ...

Findings showed 46.4% of patients treated with upadacitinib 15mg achieved sustained remission compared with 29.0% of those who received placebo. The Food and Drug Administration (FDA) has approved ...

The US Food and Drug Administration (FDA) has approved a new indication for upadacitinib as a treatment for giant cell arteritis (GCA) in adults. This is the first oral JAK inhibitor indicated for ...

The FDA has approved upadacitinib to treat adults with giant cell arteritis. It is the second drug to be specifically approved for the disease in the United States after tocilizumab in 2017.

for the treatment of adults with giant cell arteritis (GCA). 1 This comes after the European Commission recently granted marketing authorization of RINVOQ for the treatment of GCA in adult patients.

for the treatment of adults with giant cell arteritis (GCA). According to InvestingPro data, the company maintains strong financials with revenues of $57.4 billion and an impressive gross profit ...

AbbVie announced the US Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA). This comes after the ...